FDA grants accelerated approval to BEQALZI for relapsed mantle cell lymphoma

Astrazeneca’s Baxfendy wins US approval as first-in-class hypertension drug

Baxfendy works in a fundamentally different way from current therapies

Wegovy delivers consistent weight loss & heart benefits for women across menopause: Novo Nordisk study

Nearly one in five women worldwide are now living with obesity

Breakthrough wearable heart failure therapy enables earlier hospital discharge: UK trial

Researchers reported that patients treated with the wearable system were discharged around five days earlier than those receiving standard hospital-based care

NIH-funded study uncovers hidden brain circuit behind GLP-1 weight-loss drugs

In the new study, scientists at the University of Virginia used gene-editing techniques to modify GLP-1 receptors in mice to make them more humanlike

Laser-based framework to precisely control liquid droplets

Study published BY IIT Kanpur researchers could advance drug delivery and biomedical technologies

Dr. Jitendra Singh calls for stronger research ecosystem

The Union Minister reviewed DST-supported SATHI-BHU facility

Bristol Myers Squibb wins EU nod for Sotyktu in active psoriatic arthritis

The once-daily oral therapy is the first and only tyrosine kinase 2 (TYK2) inhibitor approved in the European Union for this indication, marking a significant expansion of its immunology portfolio

Eli Lilly unveils $4.5 bn Indiana expansion

The investment will upgrade and expand production capabilities at Lilly Lebanon API and Lilly Lebanon Advanced Therapies

Eton Pharmaceuticals relaunches HEMANGEOL with new distribution model

The company says the product will now be distributed exclusively through Anovo Specialty Pharmacy